Supplementary Figure 3 from γ-H2AX Foci Formation as a Pharmacodynamic Marker of DNA Damage Produced by DNA Cross-Linking Agents: Results from 2 Phase I Clinical Trials of SJG-136 (SG2000)
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 56K, Mean foci per cell versus dose of SJG-136 administered for the CRUK (upper) and NCI (middle) clinical trials, and mean foci per cell versus cross-linking (% decrease in tail moment) for the NCI trial (bottom).
Language: English
Topic: DNA Repair Mechanisms
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361908346